These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32779325)

  • 21. Expanding the Donor Pool With the Use of Extended Criteria Donation After Circulatory Death Livers.
    Mihaylov P; Mangus R; Ekser B; Cabrales A; Timsina L; Fridell J; Lacerda M; Ghabril M; Nephew L; Chalasani N; Kubal CA
    Liver Transpl; 2019 Aug; 25(8):1198-1208. PubMed ID: 30929303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of deceased donor liver biopsy: An analysis of 5449 liver transplant recipients.
    Patel MS; Mohebali J; Coe TM; Sally M; Groat T; Niemann CU; Malinoski DJ; Vagefi PA
    Clin Transplant; 2020 May; 34(5):e13835. PubMed ID: 32068301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Liver Transplantation Using Pediatric Deceased Donor Livers: A Single-Center Analysis of 102 Donors.
    Zhang R; Zhu ZJ; Sun LY; Wei L; Qu W
    Chin Med J (Engl); 2018 Mar; 131(6):677-683. PubMed ID: 29521290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
    Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
    Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the Effect of Transplanting Older Donor Livers Into Younger Recipients: The Need for Donor-recipient Age Matching.
    Bittermann T; Goldberg DS
    Transplantation; 2018 Dec; 102(12):2033-2037. PubMed ID: 29965955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postreperfusion hyperkalemia in liver transplantation using donation after cardiac death grafts with pathological changes.
    Zhang WJ; Xia WL; Pan HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):487-492. PubMed ID: 27733317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
    Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Center Experience Using Marginal Liver Grafts in Korea.
    Park PJ; Yu YD; Yoon YI; Kim SR; Kim DS
    Transplant Proc; 2018 May; 50(4):1147-1152. PubMed ID: 29731083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of donor non-alcoholic fatty liver disease following liver transplantation.
    Posner AD; Sultan ST; Zaghloul NA; Twaddell WS; Bruno DA; Hanish SI; Hutson WR; Hebert L; Barth RN; LaMattina JC
    Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28636211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
    Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
    Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.
    Kaldas FM; Korayem IM; Russell TA; Agopian VG; Aziz A; DiNorcia J; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
    JAMA Surg; 2019 May; 154(5):431-439. PubMed ID: 30758485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe Unresolved Cholestasis Due to Unknown Etiology Leading to Early Allograft Failure Within the First 3 Months of Liver Transplantation.
    Angelico R; Gerlach UA; Gunson BK; Neil D; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MTP
    Transplantation; 2018 Aug; 102(8):1307-1315. PubMed ID: 29470351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation.
    Levesque E; Hoti E; Khalfallah M; Salloum C; Ricca L; Vibert E; Azoulay D
    Liver Transpl; 2011 Oct; 17(10):1159-66. PubMed ID: 21744468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding donor age in liver transplantation using liver grafts from nonagenarian donors.
    Caso Maestro O; Justo Alonso I; Marcacuzco Quinto A; Manrique Municio A; Calvo Pulido J; García-Sesma A; Jiménez-Romero C
    Clin Transplant; 2022 Jul; 36(7):e14684. PubMed ID: 35462445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of donor body mass index on graft function in liver transplantation: A systematic review.
    Takagi K; de Wilde RF; Polak WG; IJzermans JNM
    Transplant Rev (Orlando); 2020 Oct; 34(4):100571. PubMed ID: 33002669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation.
    Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE
    Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.
    Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A
    Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.